Drawing for TYRRS TRIAD

USPTO serial 99749361

TYRRS TRIAD

Status 641Office Action
Filing date
Apr 7, 2026
Status date
Aug 10, 2026
Registration date
Examiner
COUEY,JORDAN ELIZABETH

Need help with TYRRS TRIAD?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: November 10, 2026

Office Action issues

The examiner issued refusals due to likelihood of confusion with an existing mark, an unacceptable specimen, and a required disclaimer for descriptive wording.

Owner

  • Functional Longevity Labs, Inc.

    Easton, MD, US

Goods and services

ClassDescriptionStatusFirst use
005Therapeutic pharmaceutical for the treatment of neurodegeneration; Nutraceuticals for use as a dietary supplementACTIVEApr 7, 2026

Prosecution history

DateCodeEvent
Aug 10, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2026GNRTNON-FINAL ACTION E-MAILED
Aug 10, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 29, 2026DOCKASSIGNED TO EXAMINER
Apr 7, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Apr 7, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2026NWAPNEW APPLICATION ENTERED

Related guidance